Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 917 | 1038 | 821 | 1226 | - |
Fund Return | 3.84% | -8.26% | 3.84% | -6.37% | 4.16% | - |
Place in category | 42 | 71 | 42 | 49 | 13 | - |
% in Category | 34 | 58 | 34 | 41 | 19 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 34.86B | 12.69 | 5.65 | 10.55 | ||
T. Rowe Price Blue Chip Growth | 32.17B | 35.63 | 7.54 | 14.89 | ||
T. Rowe Price Blue Chip Growth I | 30.56B | 35.79 | 7.68 | - | ||
T. Rowe Price Capital AppreciationI | 29.47B | 12.84 | 5.78 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.27B | 30.99 | 7.47 | 16.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 4.75B | 1.05 | -2.31 | 4.99 | ||
Fidelity Series International Sm C | 3.78B | 5.03 | -2.86 | 7.58 | ||
Artisan International Small Cap Ins | 3.13B | -0.24 | -5.37 | - | ||
T. Rowe Price International Discov | 2.03B | 3.67 | -6.52 | 6.80 | ||
Oppenheimer International Small-MiI | 1.9B | -6.11 | -9.92 | 6.65 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BAWAG | AT0000BAWAG2 | 2.06 | 89.550 | +2.11% | |
MercadoLibre | US58733R1023 | 1.74 | 1,828.73 | +0.56% | |
Redcare Pharmacy NV | NL0012044747 | 1.62 | 122.400 | +5.15% | |
Spie | FR0012757854 | 1.44 | 31.36 | +0.13% | |
China Resources Mixc | KYG2122G1064 | 1.23 | 28.30 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | Sell |
Summary | Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review